The long-term outcomes of pediatric pleural empyema: a prospective study
- PMID: 22945017
- DOI: 10.1001/archpediatrics.2012.1055
The long-term outcomes of pediatric pleural empyema: a prospective study
Abstract
Objective: To describe the long-term outcomes of pediatric pleural empyema.
Design: Prospective observational study from October 2008 to October 2011.
Setting: Tertiary care children's hospital.
Participants: Children with pleural empyema (loculations and/or septations identified on radiologic imaging or frank pus on thoracentesis).
Main outcome measures: Children were seen 1, 6, and 12 months postdischarge. Outcome measures included symptoms and signs of respiratory disease, child and parental impact, radiographic resolution, spirometry, and health-related quality of life (Pediatric Quality of Life Inventory score). Analysis was based on the last observation carried forward for missing data.
Results: Eighty-two of 88 patients (93%) eligible were recruited. Fifty-four percent were male and mean (SD) age was 4.5 (3.4) years. Outcome data was obtained in 100% at 1 month, 90% at 6 months, and 72% at 1 year. Seventy-one percent had effusions occupying a quarter or more of the hemithorax and 62% of effusions were drained. Fever, cough, parental work loss, child school loss, radiographic abnormalities, and abnormal spirometry results were common in the first month and then declined. By the last observation, 2% of patients had abnormal radiographs (aside from pleural thickening), 6% had mild obstruction on spirometry, and Pediatric Quality of Life Inventory scores were better than for children with asthma (P < .001). Patients with abnormal outcomes in 1 measure had normal outcomes in all other clinical measures.
Conclusions: Clinically important phenomena persist in the short-term, but virtually all children with pleural empyema have no long-term sequelae.
Comment in
-
Long-term outcomes in children with pleural empyema.Arch Pediatr Adolesc Med. 2012 Nov;166(11):1069-71. doi: 10.1001/archpediatrics.2012.1713. Arch Pediatr Adolesc Med. 2012. PMID: 22945034 No abstract available.
Similar articles
-
Prospective evaluation of lung function in children with parapneumonic empyema.Pediatr Pulmonol. 2019 Apr;54(4):421-427. doi: 10.1002/ppul.24204. Epub 2018 Dec 27. Pediatr Pulmonol. 2019. PMID: 30589234
-
Treatment of encapsulated pleural effusions in children: a prospective trial.Pediatr Int. 2010 Jun;52(3):453-8. doi: 10.1111/j.1442-200X.2009.03006.x. Epub 2009 Nov 16. Pediatr Int. 2010. PMID: 19919636
-
Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children.Acta Paediatr. 2004 Nov;93(11):1443-5. doi: 10.1111/j.1651-2227.2004.tb02626.x. Acta Paediatr. 2004. PMID: 15513569 Clinical Trial.
-
Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis.Pediatrics. 2005 Jun;115(6):1652-9. doi: 10.1542/peds.2004-1405. Pediatrics. 2005. PMID: 15930229 Review.
-
The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee.J Pediatr Surg. 2012 Nov;47(11):2101-10. doi: 10.1016/j.jpedsurg.2012.07.047. J Pediatr Surg. 2012. PMID: 23164006 Review.
Cited by
-
Long-Term Respiratory Outcome of Children with Empyema.Indian J Pediatr. 2024 Jun;91(6):632. doi: 10.1007/s12098-024-05021-4. Epub 2024 Jan 15. Indian J Pediatr. 2024. PMID: 38224429 No abstract available.
-
From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.Front Pharmacol. 2022 Jan 20;12:806393. doi: 10.3389/fphar.2021.806393. eCollection 2021. Front Pharmacol. 2022. PMID: 35126140 Free PMC article. Review.
-
Recent Insights into the Management of Pleural Infection.Int J Gen Med. 2021 Jul 14;14:3415-3429. doi: 10.2147/IJGM.S292705. eCollection 2021. Int J Gen Med. 2021. PMID: 34290522 Free PMC article. Review.
-
Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.JAMA Pediatr. 2020 Apr 1;174(4):332-340. doi: 10.1001/jamapediatrics.2019.5863. JAMA Pediatr. 2020. PMID: 32011642 Free PMC article. Clinical Trial.
-
Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.Trials. 2017 Jun 24;18(1):293. doi: 10.1186/s13063-017-2026-0. Trials. 2017. PMID: 28646887 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
